EMA Starts ‘Rolling Review’ Of AstraZeneca’s COVID-19 Vaccine
The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.
You may also be interested in...
EU Approval Of COVID-19 Vaccines Possible In Weeks
The European Medicines Agency will continue working over the Christmas period so that it can complete its assessment of the newly filed marketing applications for BioNTech/Pfizer’s and Moderna’s COVID-19 vaccines as soon possible.
Oxford/AstraZeneca Vaccine Shows 70% Efficacy As Company Prepares Approval Filings
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Coronavirus Notebook: EU Strikes Deals For Gilead’s Veklury, Janssen’s Vaccine
Russia is planning to register a second COVID-19 vaccine this month, while the UK is ramping up its manufacturing capacity for vaccines and therapeutics.